Alexandre Morrot Selected Research

Parasitic Diseases (Parasitic Disease)

1/2017	Host-Toxoplasma gondii Coadaptation Leads to Fine Tuning of the Immune Response.
1/2017	Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis.
1/2013	The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.
7/2012	Extrathymic CD4+CD8+ lymphocytes in Chagas disease: possible relationship with an immunoendocrine imbalance.
8/2011	Chagasic thymic atrophy does not affect negative selection but results in the export of activated CD4+CD8+ T cells in severe forms of human disease.
9/2006	Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Morrot Research Topics

Disease

42	Infections 06/2023 - 11/2006
11	Neoplasms (Cancer) 06/2023 - 01/2013
11	Chagas Disease (American Trypanosomiasis) 01/2019 - 07/2012
8	Malaria 01/2019 - 09/2002
6	Visceral Leishmaniasis (Kala Azar) 01/2018 - 11/2012
6	Parasitic Diseases (Parasitic Disease) 01/2017 - 09/2006
5	COVID-19 01/2023 - 09/2021
5	Atrophy 01/2015 - 08/2011
4	Cryptococcosis 06/2023 - 11/2018
3	Peritonitis 01/2023 - 01/2015
3	Leishmaniasis 01/2022 - 01/2014
2	Pneumonia (Pneumonitis) 01/2023 - 10/2022
2	Adenocarcinoma 01/2023 - 04/2020
2	Sepsis (Septicemia) 01/2023 - 10/2022
2	Mycoses (Diseases, Fungus) 06/2022 - 01/2021
2	Cerebral Malaria 01/2019 - 01/2013
2	Cutaneous Leishmaniasis 01/2017 - 01/2014
2	Inflammation (Inflammations) 01/2015 - 11/2006
1	Neoplasm Metastasis (Metastasis) 06/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Hepatitis 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Acute Lung Injury 01/2023
1	Critical Illness (Critically Ill) 11/2021
1	Neuroinflammatory Diseases 10/2021
1	Guillain-Barre Syndrome 09/2021
1	COVID-19 related pediatric multisystem inflammatory disease 09/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2021
1	Autoimmune Diseases (Autoimmune Disease) 09/2021
1	Human Influenza (Influenza) 01/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Thrombosis (Thrombus) 11/2020
1	Hepatocellular Carcinoma (Hepatoma) 04/2020
1	Adenocarcinoma of Lung 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Heart Failure 01/2018
1	Myocardial Infarction 01/2018
1	Zika Virus Infection 01/2018

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 04/2023 - 10/2014
8	Polysaccharides (Glycans)IBA 06/2023 - 01/2016
8	AntigensIBA 01/2018 - 09/2002
7	VaccinesIBA 01/2021 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
4	AntibodiesIBA 01/2022 - 02/2015
4	Immunoglobulin G (IgG)IBA 01/2021 - 02/2015
4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2015
3	Virulence Factors (Pathogenicity Factors)IBA 06/2023 - 01/2016
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2022 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 11/2007
3	MucinsIBA 01/2019 - 11/2006
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2015
3	N-Glycosyl HydrolasesIBA 01/2017 - 01/2014
2	SugarsIBA 06/2023 - 05/2022
2	Capsules (Microcapsules)IBA 06/2023 - 01/2021
2	GlycoconjugatesIBA 01/2023 - 06/2022
2	CarbohydratesIBA 01/2023 - 01/2017
2	Neuraminidase (Sialidase)IBA 01/2023 - 10/2022
2	Oseltamivir (Tamiflu)FDA Link 01/2023 - 10/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2022
2	EnzymesIBA 01/2023 - 01/2018
2	Zanamivir (Relenza)FDA Link 01/2023 - 10/2022
2	Peptides (Polypeptides)IBA 01/2023 - 08/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2017
2	Toll-Like Receptor 9IBA 08/2022 - 01/2021
2	AutoantibodiesIBA 09/2021 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 11/2018 - 10/2014
2	Interleukin-6 (Interleukin 6)IBA 11/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 01/2018
2	EpitopesIBA 01/2017 - 07/2003
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2015 - 10/2014
2	GlucocorticoidsIBA 11/2013 - 07/2012
2	BradykininIBA 11/2012 - 11/2006
2	Bradykinin B2 ReceptorIBA 11/2012 - 11/2006
2	Hormones (Hormone)IBA 07/2012 - 01/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2012 - 08/2011
1	CollagenIBA 04/2023
1	AcetylgalactosamineIBA 01/2023
1	oncofetal fibronectinIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Uridine Diphosphate (UDP)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	GlycosyltransferasesIBA 01/2023
1	Sialic AcidsIBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Immunoglobulin M (IgM)IBA 01/2021
1	AmidesIBA 04/2020
1	piperineIBA 04/2020
1	HexosaminesIBA 01/2019
1	DiazooxonorleucineIBA 01/2019
1	GlycolipidsIBA 01/2018
1	GD3 ganglioside (GD(3))IBA 01/2018

Therapy/Procedure

3	Immunotherapy 01/2023 - 01/2014
3	Immunomodulation 01/2023 - 01/2018
3	Therapeutics 11/2020 - 12/2015
2	Drug Therapy (Chemotherapy) 02/2017 - 12/2015